111
Views
13
CrossRef citations to date
0
Altmetric
Biomarkers

Utility of Two-Compartment Models of Exhaled Nitric Oxide in Patients with Asthma

, Ph.D., , M.D. & , M.D.
Pages 329-334 | Published online: 19 Apr 2011

References

  • Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524–526.
  • Stewart L, Katial R. Exhaled nitric oxide. Immunol Allergy Clin North Am 2007; 27:571–586.
  • Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, Bousquet J, Godard P, Holgate S, Polak JM.Induction of nitric oxide synthase in asthma. Lancet 1993; 342:1510–1513.
  • Marshall HE, Stamler JS. NO waiting to exhale in asthma. Am J Respir Crit Care Med 2000; 161:685–687.
  • Silkoff PE, Robbina RA, Gaston B, Landberg JOM, Townley RG. Endogenous nitric oxide in allergic airway disease. J Allergy Clin Immunol 2000; 115:438–448.
  • Sanders P, Slekierski ES, Richards SM, Porter JD, Imani F, Proud D. Rhinovirus infection induces expression of type 2 nitric oxide synthase in human respiratory epithelial cells in vitro and in vivo. J Allergy Clin Immunol 2001; 107:235–243.
  • Kao YT, Piedra PA, Larsen GL, Colasurdo GN. Induction and regulation of nitric oxide synthase in airway epithelial cells by respiratory syncitial virus. Am J Respir Crit Care Med 2001; 163:532–539.
  • American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171:912–930.
  • Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996; 153:454–457.
  • de Diego Damiá A. Nitric oxide in asthma: what good does it do? Arch Bronconeumol 2010; 46:157–159.
  • Silkoff PE, McClean PA, Caramori M, Slutsky AS, Zamel N. A significant proportion of exhaled nitric oxide arises in the large airways in normal subjects. Respir Physiol 1998; 113:33–38.
  • Jörres RA. Modelling the production of nitric oxide within the human airways. Eur Respir J 2000; 16:555–560.
  • Silkoff PE, McClean PA, Slutsky AS, Furlott HG, Hoffstein E, Wakita S, Chapman KR, Szalai JP, Zamel N. Marked flow dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med 1997; 155:260–267.
  • Tsoukias NM, George SC. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 1998; 85:653–666.
  • Tsoukias NM, Tannous Z, Wilson AF, George SC. Single exhalation profiles of NO and CO2 in humans: effect of dynamically changing flow rate. J Appl Physiol 1998; 85:642–652.
  • Fortuna AM, Balleza M, Calaf N, González M, Feixas T, Casan P. Determining the alveolar component of nitric oxide in exhaled air: procedures and reference values for healthy persons. Arch Bronconeumol 2009; 45:145–149.
  • Silkoff PE, Sylvester JT, Zamel N, Permutt S. Airway nitric oxide diffusion in asthma. Role of pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med 2000; 161:1218–1228.
  • Pietropaoli AP, Perillo IB, Torres A, Perkins PT, Frasier LM, Utell MJ, Frampton MW, Hyde RW. Simultaneous measurement of nitric oxide production by conducting and alveolar airways of humans. J Appl Physiol 1999; 87:1532–1542.
  • Hogman M, Holmkvist T, Wegener T, Emtner M, Andersson M, Hedenstrm H, Meriläinen P. Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis. Respir Med 2002; 96:24–30.
  • George SC, Hogman M, Permutt S, Silkoff PE. Modelling pulmonary nitric oxide exchange. J Appl Physiol 2004; 96:831–839.
  • Shin HW, George SC. Impact of axial diffusion on nitric oxide exchange in the lungs. J Appl Physiol 2002; 93:2070–2080.
  • Kerckx Y, Michils A, Van Muylem A. Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients. J Appl Physiol 2008; 104:918–924.
  • Condorelli P, Shin HW, Aledia AS, Silkoff PE, George SC. A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model. J Appl Physiol 2007; 102:417–425.
  • Shin HW, Condorelli P, George SC. A new and more accurate technique to characterize airway nitric oxide using different breath-hold times. J Appl Physiol 2005; 98:1869–77.
  • Condorelli P, Shin HW, George SC. Characterizing airway and alveolar nitric oxide exchange during tidal breathing using a three-compartment model. J Appl Physiol 2004; 96:1832–1842.
  • Malinovschi A, Ch J, Holmkvist T, Norbäck D, Meriläinen P, Högman M. IgE sensitisation in relation to flow-independent nitric oxide exchange parameters. Respir Res 2006; 7:92.
  • Fang K, Johns R, Macdonald T, Kinter M, Gaston B. S-nitrosoglutathione breakdown prevents airway smooth muscle relaxation in the guinea pig. Am J Physiol Lung Cell Mol Physiol 2000; 279:L716–L721.
  • Hunt JF, Fang K, Malik R, Snyder A, Malhotra N, Platts-Mills TA, Gaston B. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000; 161:694–699.
  • Shin HW, Rose-Gottron CM, Cooper DM, Newcombe RL, George SC. Airway diffusing capacity of nitric oxide and steroid therapy in asthma. J Appl Physiol 2004; 96:65–75.
  • Lehtimäki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J 2001; 18:635–639.
  • Linn WS, Rappaport EB, Berhane KT, Bastain TM, Salam MT, Gilliland FD. Extended exhaled nitric oxide analysis in field surveys of schoolchildren: a pilot test. Pediatr Pulmonol 2009; 44:1033–1042.
  • Mahut B, Delacourt Ch, Zerah-Lancner F, De Blic J, Harf A, Delclaux Ch. Increase in alveolar nitric oxide in the presence of symptoms in childhood asthma. Chest 2004; 125:1012–1018.
  • Puckett JL, Taylor RW, Leu SY, Guijon OL, Aledia AS, Galant SP, George SC. An elevated bronchodilator response predicts large airway inflammation in mild asthma. Pediatr Pulmonol 2010; 45:174–181.
  • Lehtimäki L, Kankaanranta H, Saarelainen S, Hahtola P, Järvenpää R, Koivula T, Turjanmaa V, Moilanen E. Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med 2001; 163:1557–1561.
  • Gelb AF, Taylor CF, Nussbaum E, Gutierrez C, Schein A, Shinar CM, Schein MJ, Epstein JD, Zamel N. Alveolar and airway sites of nitric oxide inflammation in treated asthma. Am J Respir Crit Care Med 2004; 170:737–741.
  • Berry M, Hargadon B, Morgan A, Shelley M, Richter J, Shaw D, Green RH, Brightling C, Wardlaw AJ, Pavord ID. Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J 2005; 25:986–991.
  • Iijima H, Duguet A, Eum SY, Hamid Q, Eidelman DH. Nitric oxide and protein nitration are eosinophil dependent in allergen challenged mice. Am J Respir Crit Care Med 2001; 163:1233–1240.
  • Battaglia S, den Hertog H, Timmers MC, Lazeroms SP, Vignola AM, Rabe KF, Bellia V, Hiemstra PS, Sterk PJ. Small airways function and molecular markers in exhaled air in mild asthma. Thorax 2005; 60:639–644.
  • Mahut B, Trinquart L, Le Bourgeois M, Becquemin MH, Beydon N, Aubourg F, Jala M, Bidaud-Chevalier B, Dinh-Xuan AT, Randrianarivelo O, Denjean A, de Blic J, Delclaux C. Multicentre trial evaluating alveolar NO fraction as a marker of asthma control and severity. Allergy 2010; 65:636–644.
  • Lehtimäki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms. Eur Respir J 2002; 20:841–845.
  • Ten Hacken NH, Postma DS, Drok G, Smith M, Kraan J, Timens W. Increased vascular expression of iNOS at day but not at night in asthmatic subjects with increased nocturnal airway obstruction. Eur Respir J 2000; 16:445–451.
  • Gabbay E, Walters EH, Orsida B, Whitford H, Ward C, Kotsimbos TC, Snell GI, Williams TJ. Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase. Am J Respir Crit Care Med 2000; 162:2182–2187.
  • Verbanck S, Schuermans D, Vincken W. Inflammation and airway function in the lung periphery of patients with stable asthma. J Allergy Clin Immunol 2010; 125:611–616.
  • van Veen IH, Sterk PJ, Schot R, Gauw SA, Rabe KF, Bel EH. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J 2006; 27:951–956.
  • Fritscher LG, Rodrigues MT, Zamel N, Chapman KR. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Respir Med 2009; 103:296–300.
  • Cohen J, Douma WR, ten Hacken NHT, Vonk JM, Oudkerk M, Postma DS. Ciclesonide improves measures of small airway involvement in asthma. Eur Respir J 2008; 31:1213–1220.
  • Puckett JL, Taylor RW, Leu SY, Guijon OL, Aledia AS, Galant SP, George SC. Clinical patterns in asthma based on proximal and distal airway nitric oxide categories. Respir Res 2010; 11:47.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.